Cargando…

Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5

INTRODUCTION: Amyloid-related decline in semantic memory was recently shown to be observable in the preclinical period of Alzheimer's disease. Cognitive composites designed to be sensitive to cognitive change in preclinical Alzheimer's disease (e.g., preclinical Alzheimer's cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papp, Kathryn V., Rentz, Dorene M., Orlovsky, Irina, Sperling, Reisa A., Mormino, Elizabeth C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726754/ https://www.ncbi.nlm.nih.gov/pubmed/29264389 http://dx.doi.org/10.1016/j.trci.2017.10.004

Ejemplares similares

Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi‐site cohort
por: Young, Christina B., et al.
Publicado: (2023)

Amyloid-associated increases in longitudinal report of subjective cognitive complaints
por: Amariglio, Rebecca E., et al.
Publicado: (2018)

Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Rentz, Dorene M., et al.
Publicado: (2020)

Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing
por: Seghezzo, Giulia, et al.
Publicado: (2021)

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
por: Rentz, Dorene M, et al.
Publicado: (2013)

The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults
por: Orlovsky, Irina, et al.
Publicado: (2017)

Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease
por: Samaroo, Aubryn, et al.
Publicado: (2021)

Relation of modifiable lifestyle and mood factors to cognitive concerns among participants and their study partners in the A4 screen data
por: Reynolds, Gretchen, et al.
Publicado: (2023)

Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease
por: Papp, Kathryn V., et al.
Publicado: (2021)

Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease
por: Jutten, Roos J., et al.
Publicado: (2022)

Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
por: Hanseeuw, Bernard J., et al.
Publicado: (2019)

Cross-validation of optimized composites for preclinical Alzheimer's disease
por: Donohue, Michael C., et al.
Publicado: (2016)

The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer’s disease
por: Vila-Castelar, Clara, et al.
Publicado: (2020)

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial
por: Raman, Rema, et al.
Publicado: (2021)

Preclinical Alzheimer's disease and longitudinal driving decline
por: Roe, Catherine M., et al.
Publicado: (2016)

Longitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer’s Disease Biomarkers and Mood Symptoms
por: Munro, Catherine E., et al.
Publicado: (2022)

Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
por: Buckley, Rachel F., et al.
Publicado: (2019)

APOE effects on regional tau in preclinical Alzheimer’s disease
por: Young, Christina B., et al.
Publicado: (2023)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer’s disease
por: Halawa, Omar A., et al.
Publicado: (2019)

Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system
por: Grober, Ellen, et al.
Publicado: (2021)

Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study
por: Grober, Ellen, et al.
Publicado: (2022)

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease
por: Norton, Daniel J., et al.
Publicado: (2020)

Association of anxiety with subcortical amyloidosis in cognitively normal older adults
por: Hanseeuw, Bernard J., et al.
Publicado: (2018)

Cognition, Reserve, and Amyloid Deposition in Normal Aging
por: Rentz, Dorene M, et al.
Publicado: (2010)

Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults
por: Hanseeuw, Bernard J., et al.
Publicado: (2018)

Multiple markers contribute to risk of progression from normal to mild cognitive impairment
por: Rabin, Jennifer S., et al.
Publicado: (2020)

Decreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults
por: Vannini, Patrizia, et al.
Publicado: (2019)

Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
por: Kirsebom, Bjørn-Eivind, et al.
Publicado: (2018)

Validating Use of Technology for Cognitive Test Assessment
por: Rentz, Dorene M.
Publicado: (2016)

A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition study
por: Jutten, Roos J., et al.
Publicado: (2017)

Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging
por: Vannini, Patrizia, et al.
Publicado: (2017)

Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals
por: Jacobs, Heidi I.L., et al.
Publicado: (2018)

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
por: Dubbelman, Mark A., et al.
Publicado: (2020)

Current advances in digital cognitive assessment for preclinical Alzheimer's disease
por: Öhman, Fredrik, et al.
Publicado: (2021)

Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults
por: Biddle, Kelsey D., et al.
Publicado: (2020)

African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials
por: Zhou, Yan, et al.
Publicado: (2016)

Lower novelty-related locus coeruleus function is associated with Aβ-related cognitive decline in clinically healthy individuals
por: Prokopiou, Prokopis C., et al.
Publicado: (2022)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease
por: Villeneuve, Sarah-Christine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_me0grre9tiv8gs29qbb025j5ou